The U.S. Food and Drug Administration issued its first formal guidance on how to design and run clinical trials for ...
For the past eight years, Compass Pathways has been fighting to convince the Food and Drug Administration that a chemical ...
In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.
Compass Pathways' synthetic psilocybin COMP360 clears Phase 3 trials, showing 39% depression reduction in 24 hours for treatment-resistant patients.
PHOENIX — An Arizona Army veteran who spent years in military service, emergency medicine and law enforcement is now part of a pioneering effort led by one of the country’s most prominent psychedelic ...
SCIENTISTS ARE LOOKING AT THE PSYCHEDELIC DRUG AS A TREATMENT FOR POSTPARTUM DEPRESSION. WESH 2 NEWS JILLIAN CAMPBELL TALKED WITH A MOM AND DOCTORS WHO SAY THIS COULD BE THE MEDICINE OF THE FUTURE.
Add Yahoo as a preferred source to see more of our stories on Google. An Arizona Army veteran who spent years in military service, emergency medicine and law enforcement is now part of a pioneering ...